Psychedelic Clinical Trials
Find clinical trials studying psilocybin, MDMA, ketamine and other psychedelics. Many trials are actively recruiting participants who haven't found relief from conventional treatments.
Virtual Reality-Based Mindfulness as an Adjunct to Treatment as Usual in Treatment-Resistant Depression
Hospital Universitari Vall d'Hebron Research Institute
Anesthesia Techniques, Neuroprotection and Surgical Field in FESS Under Controlled Hypotension
University General Hospital of Patras
Analgosedation With Ketamine, Nalbuphine, or Dexmedetomidine for Suture Removal in Children After Cleft Surgery
University Medical Centre Ljubljana
Pain Control Alternatives in Pediatric Patients With Distal Radius Fractures
State University of New York at Buffalo
Magnesium and Cramping
Corewell Health East
A Ketamine-assisted Group Therapy Intervention for Spanish-speaking Adults With Depression
Juliana Zambrano, MD, MPH
Ketamine Augmentation of ECT in Treatment-Resistant Depression
Università Vita-Salute San Raffaele
A Study of Ketamine Infusions to Treat Clinically-depressed ICU Patients
Mayo Clinic
Ketamine, SGB and Combination Treatment for TBI-associated Headache or PTSD
Northwestern University
Music as an Adjunct to Ketamine Therapy for Chronic Pain
McGill University
Working Mechanisms and Effectiveness of IV Ketamine-assisted Psychotherapy on Depression in TRD Clients
Senz
Ketamine and Neurofeedback as Combined Therapeutic Interventions to Target Glutamatergic Neurotransmission in Alcohol Use Disorder
Dr. med. Marcus Herdener
Retrospective Analyses of the Greenbrook Database Evaluating Mental Health Treatments
Neuronetics
ACT_for Alcohol Use Disorder and Depression
Centre hospitalier de l'Université de Montréal (CHUM)
Best Hypnotic Drug Choice for Rapid Sequence Induction in the Operating Room
Nantes University Hospital
Understanding and Treating Suicidal Ideation With Ketamine
The Royal's Institute of Mental Health Research
Pain Reduction for Limb Injuries in Pediatric Emergency Departments: Intranasal Fentanyl or Intranasal Ketamine vs Oral Morphine
Assistance Publique - Hôpitaux de Paris
Intravenous Ketamine for Treatment-Resistant Depression
Mayo Clinic
PCORI Comparative Effectiveness Study-Esketamine (Spravato) vs. Ketamine-Equivalence Study
Yale University
Ketamine for Combined Depression and Alcohol Use Disorder
University Hospital of North Norway
Ketamine-Assisted Psychotherapy (KAP) Compared to Ketamine Alone for the Treatment of Depression
Icahn School of Medicine at Mount Sinai
Ketamine Sedation As Neuroprotective Agent Following Out-of-hospital Cardiac Arrest
Christian Hassager
Endometriosis and Pain Treatment by Intraoperative Administration of Low-dose Ketamine
Insel Gruppe AG, University Hospital Bern
Veteran's Perceptions of Ketamine-Assisted Psychotherapy for Depression and End-of-Life
Albany Research Institute, Inc.
Investigation of the Antidepressant Effects of (2R,6R)-HNK, an Enhancer of Synaptic Glutamate Release, in Treatment-Resistant Depression
National Institute of Mental Health (NIMH)
Early Effects of Ketamine vs Placebo With Venlafaxine in Severe Depression Patients
Assistance Publique - Hôpitaux de Paris
Nebulized Ketamine for the Treatment of Major Depressive Disorder
Theresa Jacob, PhD, MPH
The Effect of Outpatient Ketamine Infusion on Chronic Neuropathic Pain and PTSD
Margaux M. Salas, PhD
(2R,6R)-Hydroxynorketamine for the Treatment of Neuropathic Pain
Rush University Medical Center
Imaging Depression in Parkinson's Disease
Yale University
The Effect of a Six Week Intensified Pharmacological Treatment for Major Depressive Disorder Compared to Treatment as Usual in Subjects Who Had a First-time Treatment Failure on Their First-line Treatment.
Dr. Inge Winter
Low-Dose Ketamine Infusion During Burn Wound Care
University of Tennessee
Effect of Opioid-Free vs Opioid-Based Anesthesia on Postoperative Pain and Emergence Agitation in Children Undergoing Cleft Surgery
Iva Smiljanić
Belief Updating in Treatment Resistant Depression
Assistance Publique - Hôpitaux de Paris
Feasibility and Safety of Ketamine for Suicidal Patients in the Emergency Department
Lindsay Maguire, MD
Nebulized Ketamine to Nebulized Fentanyl for Treating Acute Painful Conditions in the ED
Antonios Likourezos
Pharmacologic Treatment Augmentation in Chronic Depression
University Hospital Tuebingen
Esketamine as Treatment for Chronic Pain Due to Endometriosis: a RCT Study
Reinier de Graaf Groep
Examining Mu Opioid Mechanisms of Ketamine's Rapid Effects in OCD (MKET2)
Stanford University
Ketamine and Neurofeedback-Training: Effects on Neuroplasticity in Cocaine Addiction
Dr. med. Marcus Herdener
Neural Circuit Effects of Ketamine in Depression
Icahn School of Medicine at Mount Sinai
The OBSERVE Protocol
Yale University
Fentanyl or Esketamine for Traumatic PAIN (FORE-PAIN) Trial
Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)
i-CBT and IV Ketamine for Suicidality in Treatment-Resistant Depression: A Randomized, Midazolam-Controlled Clinical Trial
University Health Network, Toronto
Gamma Oscillations as a Prognostic Marker for Ketamine Therapy in Treatment Resistant Depression
Texas A&M University
Effect of Ketamine on Intraoperative Motor Evoked Potentials
University of California, San Francisco
Prehospital Analgesia INtervention Trial (PAIN)
Jason Sperry
HNC: Human Neural Circuits Electrophysiology During Cognition
Stanford University
Browse by Condition
View all conditions →How to Join a Clinical Trial
Clinical trials are research studies that test new treatments. Participating can give you access to cutting-edge therapies while contributing to medical science. Each trial has specific eligibility criteria based on the research goals.
1. Review
Read the trial details, eligibility criteria, and what participation involves.
2. Contact
Reach out to the study team using the contact information provided.
3. Screen
Complete the screening process to determine if you're eligible.